{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:35:07Z","timestamp":1782812107958,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372775"],"award-info":[{"award-number":["82372775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171725"],"award-info":[{"award-number":["82171725"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172709"],"award-info":[{"award-number":["82172709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010257"],"award-info":[{"award-number":["2023A1515010257"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012514"],"award-info":[{"award-number":["2023A1515012514"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515012540"],"award-info":[{"award-number":["2021A1515012540"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515030272"],"award-info":[{"award-number":["2024A1515030272"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omton.2025.200992","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:59:09Z","timestamp":1747223949000},"page":"200992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing plasmacytoid dendritic cell functionality with all-trans retinoic acid for improved multiple myeloma therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Wanli","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-8135","authenticated-orcid":false,"given":"Enguang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.200992_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.200992_bib2","article-title":"Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True","volume":"21","author":"D'Agostino","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2025.200992_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax7706","article-title":"Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain","volume":"14","author":"Hasegawa","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2025.200992_bib4","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1182\/blood.2020008936","article-title":"A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed\/refractory multiple myeloma","volume":"137","author":"Wang","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200992_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMc2308544","article-title":"Genetic Basis of Relapse after GPRC5D-Targeted CAR T Cells","volume":"389","author":"Mi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.200992_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41408-021-00469-5","article-title":"CAR T-cell therapy in multiple myeloma: more room for improvement","volume":"11","author":"Teoh","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omton.2025.200992_bib7","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","article-title":"beta(2)-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression","volume":"54","author":"Hofbauer","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200992_bib8","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41598-020-58859-x","article-title":"High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling","volume":"10","author":"Romano","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.200992_bib9","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.1203373","article-title":"Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow","volume":"190","author":"Ramachandran","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2009.08.019","article-title":"Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target","volume":"16","author":"Chauhan","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.200992_bib11","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI121421","article-title":"E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs","volume":"128","author":"Bi","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.200992_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid Dendritic Cells: Development, Regulation, and Function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200992_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13238-012-2104-8","article-title":"Regulation of TLR7\/9 signaling in plasmacytoid dendritic cells","volume":"4","author":"Bao","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.omton.2025.200992_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41590-018-0136-9","article-title":"Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells","volume":"19","author":"Rodrigues","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib15","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/leu.2014.46","article-title":"A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib","volume":"28","author":"Ray","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.200992_bib16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/neu.20242","article-title":"Overview of retinoid metabolism and function","volume":"66","author":"Blomhoff","year":"2006","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.omton.2025.200992_bib17","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1080\/10408398.2018.1509201","article-title":"The success and the challenge of all-trans retinoic acid in the treatment of cancer","volume":"59","author":"Ni","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.omton.2025.200992_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm3932","article-title":"Mechanisms of retinoic acid signalling and its roles in organ and limb development","volume":"16","author":"Cunningham","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omton.2025.200992_bib19","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1073\/pnas.89.7.2694","article-title":"Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia","volume":"89","author":"Miller","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.200992_bib20","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1080\/10428194.2019.1613540","article-title":"Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all","volume":"60","author":"Stahl","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.omton.2025.200992_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1099-1069(199609)14:3<147::AID-HON582>3.0.CO;2-3","article-title":"All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL)","volume":"14","author":"Chim","year":"1996","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.omton.2025.200992_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cell.2007.02.050","article-title":"Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors","volume":"129","author":"Schug","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200992_bib23","doi-asserted-by":"crossref","first-page":"41589","DOI":"10.1074\/jbc.C300368200","article-title":"Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta\/delta","volume":"278","author":"Shaw","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200992_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.jidsymp.5650007","article-title":"Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis","volume":"11","author":"Icre","year":"2006","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.omton.2025.200992_bib25","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/leu.2015.123","article-title":"Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab","volume":"29","author":"Nijhof","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.200992_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006325","article-title":"All-trans retinoic acid improves NSD2-mediated RARalpha phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma","volume":"11","author":"Peng","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.200992_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3324\/haematol.2022.281339","article-title":"All-trans retinoic acid works synergistically with the gamma-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells","volume":"108","author":"Garcia-Guerrero","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2025.200992_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.2020009856","article-title":"RARgamma activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway","volume":"139","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200992_bib29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2020.02.042","article-title":"Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression","volume":"180","author":"Devalaraja","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200992_bib30","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3389\/fimmu.2017.01560","article-title":"All-Trans Retinoic Acid Promotes an M1- to M2-Phenotype Shift and Inhibits Macrophage-Mediated Immunity to Leishmania major","volume":"8","author":"Vellozo","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib31","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.4049\/jimmunol.1303073","article-title":"All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function","volume":"192","author":"Bhatt","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2008.09.018","article-title":"Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells","volume":"29","author":"Hill","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200992_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abo0016","article-title":"Retinoic acid for gut health","volume":"15","author":"VanHook","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.omton.2025.200992_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2025.200992_bib35","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1093\/jn\/135.12.2774","article-title":"Vitamin A status in mice affects the histone code of the phosphoenolpyruvate carboxykinase gene in liver","volume":"135","author":"Scribner","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.omton.2025.200992_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ni.3734","article-title":"Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation","volume":"18","author":"Gundra","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","article-title":"Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function","volume":"44","author":"Wu","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200992_bib39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.200992_bib40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41419-022-04797-7","article-title":"Cooperative effects of RIG-I-like receptor signaling and IRF1 on DNA damage-induced cell death","volume":"13","author":"Zander","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.200992_bib41","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1093\/bioinformatics\/btx502","article-title":"Metagene projection characterizes GEN2.2 and CAL-1 as relevant human plasmacytoid dendritic cell models","volume":"33","author":"Carmona-Saez","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omton.2025.200992_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","article-title":"Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma","volume":"1","author":"Zavidij","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omton.2025.200992_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.200992_bib44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3324\/haematol.2014.118000","article-title":"Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK\u2217MYC model of multiple myeloma","volume":"100","author":"Bordini","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2025.200992_bib45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood-2012-04-403733","article-title":"Proteasome inhibitors in multiple myeloma: 10 years later","volume":"120","author":"Moreau","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200992_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40170-017-0169-9","article-title":"Bortezomib resistance in multiple myeloma is associated with increased serine synthesis","volume":"5","author":"Zaal","year":"2017","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.omton.2025.200992_bib47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084190","article-title":"Type I Interferon Production of Plasmacytoid Dendritic Cells under Control","volume":"22","author":"Bencze","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2025.200992_bib49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2025.200992_bib50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/bjh.13890","article-title":"Current standard treatment of adult acute promyelocytic leukaemia","volume":"172","author":"Lo-Coco","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.200992_bib51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2141.1995.tb08363.x","article-title":"Retinoic acid inhibits the growth of human myeloma cells in vitro","volume":"89","author":"Palumbo","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.200992_bib52","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/10428190310001628158","article-title":"Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I\/II trial","volume":"45","author":"Koskela","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.omton.2025.200992_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.07.002","article-title":"The role of retinoic acid in tolerance and immunity","volume":"35","author":"Hall","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200992_bib54","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41598-024-52322-x","article-title":"All-trans retinoic acid alleviates collagen-induced arthritis and promotes intestinal homeostasis","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.200992_bib55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ni.1719","article-title":"Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma","volume":"10","author":"Goswami","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib56","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-09-245274","article-title":"Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells","volume":"115","author":"Guilliams","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200992_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4049\/jimmunol.1300193","article-title":"Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance","volume":"191","author":"Khare","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200992_bib58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2009.02.046","article-title":"Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells","volume":"137","author":"Eksteen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omton.2025.200992_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/08916930903510880","article-title":"Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity","volume":"43","author":"Rizza","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.omton.2025.200992_bib60","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2025.200992_bib61","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2025.200992_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2013.12.004","article-title":"Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses","volume":"25","author":"Yang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.200992_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","article-title":"L1 drives IFN in senescent cells and promotes age-associated inflammation","volume":"566","author":"De Cecco","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.200992_bib64","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omton.2025.200992_bib65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omton.2025.200992_bib66","series-title":"A package for survival analysis in R","author":"Therneau","year":"2020"},{"key":"10.1016\/j.omton.2025.200992_bib67","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032992500061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032992500061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:02:51Z","timestamp":1762657371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295032992500061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S295032992500061X"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.200992","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing plasmacytoid dendritic cell functionality with all-trans retinoic acid for improved multiple myeloma therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.200992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200992"}}